Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Adv Healthc Mater ; 3(10): 1648-54, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24711341

RESUMEN

The development of novel oral drug delivery platforms for administering therapeutics in a safe and effective manner through the harsh gastrointestinal environment is of great importance. Here, the use of engineered thin planar poly(methyl methacrylate) (PMMA) microdevices is tested to enhance oral bioavailability of acyclovir, a poorly permeable drug. Acyclovir is loaded into the unidirectional drug releasing microdevice reservoirs using a drug entrapping photocross-linkable hydrogel matrix. An increase in acyclovir permeation across in vitro caco-2 monolayer is seen in the presence of microdevices as compared with acyclovir-entrapped hydrogels or free acyclovir solution. Cell proliferation studies show that microdevices are relatively nontoxic in nature for use in in vivo studies. Enhanced in vivo retention of microdevices is observed as their thin side walls experience minimal peristaltic shear stress as compared with spherical microparticles. Unidirectional acyclovir release and enhanced retention of microdevices achieve a 4.5-fold increase in bioavailability in vivo as compared with an oral gavage of acyclovir solution with the same drug mass. The enhanced oral bioavailability results suggest that thin, planar, bioadhesive, and unidirectional drug releasing microdevices will significantly improve the systemic and localized delivery of a broad range of oral therapeutics in the near future.


Asunto(s)
Sistemas de Liberación de Medicamentos/instrumentación , Microtecnología/instrumentación , Aciclovir/administración & dosificación , Aciclovir/química , Aciclovir/farmacocinética , Animales , Disponibilidad Biológica , Células CACO-2 , Sistemas de Liberación de Medicamentos/métodos , Diseño de Equipo , Humanos , Absorción Intestinal , Ratones , Ratones Endogámicos C57BL , Microtecnología/métodos , Modelos Químicos
2.
Proc Natl Acad Sci U S A ; 105(52): 20575-82, 2008 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-19106295

RESUMEN

Patterns of behavior exhibited by mice in their home cages reflect the function and interaction of numerous behavioral and physiological systems. Detailed assessment of these patterns thus has the potential to provide a powerful tool for understanding basic aspects of behavioral regulation and their perturbation by disease processes. However, the capacity to identify and examine these patterns in terms of their discrete levels of organization across diverse behaviors has been difficult to achieve and automate. Here, we describe an automated approach for the quantitative characterization of fundamental behavioral elements and their patterns in the freely behaving mouse. We demonstrate the utility of this approach by identifying unique features of home cage behavioral structure and changes in distinct levels of behavioral organization in mice with single gene mutations altering energy balance. The robust, automated, reproducible quantification of mouse home cage behavioral structure detailed here should have wide applicability for the study of mammalian physiology, behavior, and disease.


Asunto(s)
Conducta Animal , Metabolismo Energético , Animales , Metabolismo Energético/genética , Femenino , Masculino , Ratones , Ratones Obesos
3.
Endocrinology ; 149(3): 955-61, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18039786

RESUMEN

To investigate how serotonin and leptin interact in the regulation of energy balance and glucose homeostasis, we generated a genetic mouse model, the OB2C mouse, which lacks functional serotonin 2C receptors and the adipocyte hormone leptin. The OB2C mice exhibited a dramatic diabetes phenotype, evidenced by a synergistic increase in serum glucose levels and water intake. The severity of the animals' diabetes phenotype would not have been predicted from the phenotypic characterization of mice bearing mutations of either the leptin (OB mutant mice) or the serotonin 2C receptor gene (2C mutant mice). The synergistic impairment in glucose homeostasis developed at an age when OB2C mice did not differ in body weight from OB mice, suggesting that this impairment was not an indirect consequence of increased adiposity. We also demonstrated that the improvement in glucose tolerance in wild-type mice treated with the serotonin releaser and reuptake inhibitor fenfluramine was blunted in 2C mutant mice. These pharmacological and genetic findings provide evidence that the serotonin 2C receptor has direct effects on glucose homeostasis.


Asunto(s)
Glucosa/metabolismo , Homeostasis/fisiología , Leptina/metabolismo , Obesidad/metabolismo , Receptor de Serotonina 5-HT2C/metabolismo , Animales , Diabetes Mellitus/metabolismo , Diabetes Mellitus/patología , Diabetes Mellitus/fisiopatología , Modelos Animales de Enfermedad , Ingestión de Líquidos/fisiología , Ingestión de Alimentos/fisiología , Femenino , Fenfluramina/farmacología , Islotes Pancreáticos/patología , Islotes Pancreáticos/fisiopatología , Leptina/genética , Masculino , Ratones , Ratones Obesos , Obesidad/patología , Obesidad/fisiopatología , Receptor de Serotonina 5-HT2C/genética , Serotonina/metabolismo , Serotoninérgicos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA